Anti-CRISPR protein AcrF8 (AcrIF8) is a 92-amino acid protein encoded by temperate bacteriophage ZF40 that infects Pectobacterium carotovorum. It functions as a potent inhibitor of the host Type I-F CRISPR-Cas immune system through a unique mechanism that involves binding to both the Cas7f protein backbone and directly contacting the crRNA within the surveillance complex (Csy complex). This dual-targeting strategy physically blocks R-loop formation and prevents target DNA recognition. AcrF8 expression is tightly regulated via co-transcription with its dedicated repressor Aca2, forming a self-limiting negative feedback loop that ensures rapid deployment during infection followed by swift repression.
Definition: A molecular function that directly binds to the CRISPR RNA (crRNA) component within a CRISPR-Cas surveillance complex, thereby preventing the crRNA from base-pairing with target DNA and blocking CRISPR-Cas-mediated immunity. This is distinct from anti-CRISPR proteins that only bind to Cas protein components.
Justification: Current GO terms for anti-CRISPR activity do not distinguish between proteins that bind only to Cas proteins versus those that directly interact with the crRNA. AcrF8 represents a unique class of anti-CRISPR proteins that directly contact the RNA component of the surveillance complex, which is mechanistically distinct and evolutionarily significant. This dual protein-RNA binding strategy provides a more robust inhibition mechanism that is harder for hosts to overcome through mutation.
Supporting Evidence:
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0052170 symbiont-mediated suppression of host innate immune response | IEA GO_REF:0000043 | MODIFY | Summary: This annotation is too general for AcrF8. While it correctly captures that AcrF8 suppresses host immunity, it misses the specific mechanism of CRISPR-Cas inhibition. A more precise term would be GO:0098672 (symbiont-mediated suppression of host CRISPR-cas system), which specifically describes the function of anti-CRISPR proteins. Proposed replacements: symbiont-mediated suppression of host CRISPR-cas system Supporting Evidence: file:BPZF4/AcrF8/AcrF8-deep-research-gemini.md This report provides an exhaustive analysis of the anti-CRISPR (Acr) protein AcrF8, a key component in the immune evasion arsenal of the temperate bacteriophage ZF40. This phage infects the significant plant pathogen *Pectobacterium carotovorum*, the causative agent of soft rot diseases in numerous crops. The continuous evolutionary arms race between bacteria and their viral predators has driven the development of sophisticated defense and counter-defense systems. Within this context, AcrF8 represents a unique and highly evolved molecular weapon. This analysis delves into the intricate mechanism of CRISPR-Cas inhibition employed by AcrF8, identifies the structural domains and specific interactions that confer its function, and elucidates the elegant regulatory network that governs its expression. |
| GO:0043021 ribonucleoprotein complex binding | IDA PMID:32170016 Inhibition mechanisms of AcrF9, AcrF8, and AcrF6 against typ... | NEW | Summary: AcrF8 binds to the Type I-F CRISPR-Cas surveillance complex (Csy complex), which is a ribonucleoprotein complex containing both Cas proteins and crRNA. Structural evidence shows direct binding to both protein and RNA components. Reason: This molecular function term captures AcrF8's key mechanism of binding to the Csy ribonucleoprotein complex through direct interactions with both protein and RNA components. Supporting Evidence: PMID:32170016 The distance between the residues T29, I31, A32, N33 of AcrF8 and the nucleobases of three nucleotides (U[+21], U[+22], G[+23]) of crRNA is less than 4 Å, which is close enough to form multiple hydrogen bonds and nonbonded interactions |
| GO:0030430 host cell cytoplasm | IC PMID:32170016 Inhibition mechanisms of AcrF9, AcrF8, and AcrF6 against typ... | NEW | Summary: AcrF8 is a phage-encoded protein that acts in the cytoplasm of the infected Pectobacterium host cell, where it binds the host CRISPR-Cas surveillance complex (Csy complex). Reason: Originally proposed as GO:0005737 cytoplasm with an IEA code, but no electronic pipeline produced it and GO:0005737 is the wrong term for a viral protein acting in another organism; GO:0030430 host cell cytoplasm is the GO term for a symbiont gene product located in its host's cytoplasm. The location is inferred by curator (IC) from the binding partner, the host Csy complex, which is a cytoplasmic RNP in the bacterium; the cryo-EM structure itself was determined in vitro, so there is no direct localization experiment. AcrF8 is also synthesized inside the infected cell, being transcribed from the injected phage genome immediately after DNA injection. Supporting Evidence: PMID:31474367 acr-associated promoter drives high levels of acr transcription immediately after phage DNA injection PMID:32170016 AcrF8 is a 92-residue protein, with a single copy occupying the cavity surrounded by Cas5f, Cas7.4–7.6f, and Cas8f |
| GO:0098672 symbiont-mediated suppression of host CRISPR-cas system | IMP PMID:32170016 Inhibition mechanisms of AcrF9, AcrF8, and AcrF6 against typ... | NEW | Summary: Core function of AcrF8 as CRISPR-Cas inhibitor Reason: AcrF8 specifically inhibits the Type I-F CRISPR-Cas system by binding to the Csy surveillance complex. This is its primary biological function but was missing from existing annotations. Evidence is IMP (not IEA; no electronic pipeline asserted this term, GOA holds only GO:0052170) because the crRNA-contacting point mutants I31A and A32G relieve inhibition of Csy-mediated DNA cleavage relative to wild-type AcrF8. This row carries the experimental grounding for the term that the GO:0052170 MODIFY row proposes as its replacement. Supporting Evidence: PMID:32170016 we recombinantly expressed the AcrF8 containing a mutation at position 31 (I31A) or position 32 (A32G), which leads to an increase in the cleavage of DNA substrate compared with the WT AcrF8 PMID:32170016 AcrF8 is a 92-residue protein, with a single copy occupying the cavity surrounded by Cas5f, Cas7.4–7.6f, and Cas8f PMID:31474367 acr-associated promoter drives high levels of acr transcription immediately after phage DNA injection |
Loading supporting content…
Download this section (compressed HTML)Q: How does AcrF8's dual protein-RNA binding strategy provide evolutionary advantages over anti-CRISPRs that only target protein components?
Q: What structural features enable AcrF8 to specifically recognize and bind the crRNA within the Csy complex?
Q: How do phages coordinate expression of multiple anti-CRISPR proteins like AcrF8 and ACA2 during infection?
Experiment: Time-resolved cryo-EM to capture AcrF8 binding dynamics to the Csy complex during different stages of DNA target recognition
Experiment: Deep mutational scanning of AcrF8 to identify residues critical for RNA versus protein binding
Experiment: Single-molecule FRET to monitor how AcrF8 affects crRNA-DNA base pairing dynamics in real time
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)📊 View Pathway Visualization Interactive pathway diagram with detailed annotations